Role of vitamin D in the pathogenesis and treatment of atopic dermatitis

References

• Oyoshi MK, He R, Kumar L, Yoon J, Geha RS. Cellular and molecular mechanisms in atopic dermatitis. Adv. Immunol. 102, 135–226 (2009).
   PubMed Web of Science ®Google Scholar
• Williams HC. Is the prevalence of atopic dermatitis increasing? Clin. Exp. Dermatol. 17(6), 385–391 (1992).
   PubMed Web of Science ®Google Scholar
• Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J. Allergy. Clin. Immunol. 99(5), 673–682 (1997).
   PubMed Web of Science ®Google Scholar
• Beck LA, Boguniewicz M, Hata T et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J. Allergy. Clin. Immunol. 124(2), 260–269, 269 e261–e267 (2009).
   PubMed Web of Science ®Google Scholar
• Salt BH, Boguniewicz M, Leung DY. Severe refractory atopic dermatitis in adults is highly atopic. J. Allergy. Clin. Immunol. 119(2), 508–509 (2007).
   Google Scholar
• Leung DY, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J. Clin. Invest. 92(3), 1374–1380 (1993).
   PubMed Web of Science ®Google Scholar
• Valenta R, Seiberler S, Natter S et al. Autoallergy: a pathogenetic factor in atopic dermatitis? J. Allergy. Clin. Immunol. 105(3), 432–437 (2000).
   PubMed Web of Science ®Google Scholar
• Vassallo MF, Camargo CA. Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children. J. Allergy. Clin. Immunol. 126(2), 217–222 (2010).
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Hanifin J, Simpson EL. Climatic Factors Are Associated with Childhood Eczema Prevalence in the United States. J. Invest. Dermatol. 133(7), 1752–1759 (2013).
   PubMed Web of Science ®Google Scholar
• Osborne NJ, Ukoumunne OC, Wake M, Allen KJ. Prevalence of eczema and food allergy is associated with latitude in Australia. J. Allergy. Clin. Immunol. 129(3), 865–867 (2012).
   PubMed Web of Science ®Google Scholar
• Jones AP, Palmer D, Zhang G, Prescott SL. Cord blood 25-hydroxyvitamin d3 and allergic disease during infancy. Pediatrics 130(5), e1128–e1135 (2012).
   PubMed Web of Science ®Google Scholar
• Akan A, Azkur D, Ginis T et al. Vitamin D level in children is correlated with severity of atopic dermatitis but only in patients with allergic sensitizations. Pediatr. Dermatol. 30(3), 359–363 (2013).
   PubMed Web of Science ®Google Scholar
• Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br. J. Dermatol. 164(5), 1078–1082 (2011).
   PubMed Web of Science ®Google Scholar
• Chiu YE, Havens PL, Siegel DH et al. Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. J. Am. Acad. Dermatol. 69(1), 40–46 (2013).
   PubMed Web of Science ®Google Scholar
• Leung DY, Bieber T. Atopic dermatitis. Lancet 361(9352), 151–160 (2003).
   PubMed Web of Science ®Google Scholar
• Cork MJ, Danby SG, Vasilopoulos Y et al. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129(8), 1892–1908 (2009).
   PubMed Web of Science ®Google Scholar
• O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J. Allergy. Clin. Immunol. 122(4), 689–693 (2008).
   PubMed Web of Science ®Google Scholar
• De Benedetto A, Rafaels NM, McGirt LY et al. Tight junction defects in patients with atopic dermatitis. J. Allergy. Clin. Immunol. 127(3), 773–786 e777 (2011).
   PubMed Web of Science ®Google Scholar
• O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin. Exp. Allergy. 40(7), 965–972 (2010).
   PubMed Web of Science ®Google Scholar
• Gombert M, Dieu-Nosjean MC, Winterberg F et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174(8), 5082–5091 (2005).
   PubMed Web of Science ®Google Scholar
• Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8(2), 157–165 (2002).
   PubMed Web of Science ®Google Scholar
• Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3(7), 673–680 (2002).
   PubMed Web of Science ®Google Scholar
• Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3(9), 721–732 (2003).
   PubMed Web of Science ®Google Scholar
• Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol. Today 19(8), 359–361 (1998).
   PubMedGoogle Scholar
• Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128(11), 2625–2630 (2008).
   PubMed Web of Science ®Google Scholar
• Hijnen D, Knol EF, Gent YY et al. CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-gamma, IL-13, IL-17, and IL-22. J. Invest. Dermatol. 133(4), 973–979 (2013).
   PubMed Web of Science ®Google Scholar
• van Reijsen FC, Felius A, Wauters EA, Bruijnzeel-Koomen CA, Koppelman SJ. T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis. J. Allergy. Clin. Immunol. 101(2 Pt 1), 207–209 (1998).
   Google Scholar
• van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J. Allergy. Clin. Immunol. 90(2), 184–193 (1992).
   PubMed Web of Science ®Google Scholar
• Stary G, Bangert C, Stingl G, Kopp T. Dendritic cells in atopic dermatitis: expression of FcepsilonRI on two distinct inflammation-associated subsets. Int. Arch. Allergy. Immunol. 138(4), 278–290 (2005).
   Google Scholar
• Wollenberg A, Wagner M, Gunther S et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 119(5), 1096–1102 (2002).
   PubMed Web of Science ®Google Scholar
• Novak N, Allam JP, Hagemann T et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J. Allergy. Clin. Immunol. 114(2), 364–370 (2004).
   PubMed Web of Science ®Google Scholar
• Verhagen J, Akdis M, Traidl-Hoffmann C et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J. Allergy. Clin. Immunol. 117(1), 176–183 (2006).
   PubMed Web of Science ®Google Scholar
• Ou LS, Goleva E, Hall C, Leung DY. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J. Allergy. Clin. Immunol. 113(4), 756–763 (2004).
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347(15), 1151–1160 (2002).
   PubMed Web of Science ®Google Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch. Dermatol. 113(6), 780–782 (1977).
   PubMedGoogle Scholar
• Niebuhr M, Lutat C, Sigel S, Werfel T. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy 64(11), 1580–1587 (2009).
   Google Scholar
• Leung DY, Gao PS, Grigoryev DN et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J. Allergy. Clin. Immunol. 127(4), 965–973 e965).
   Google Scholar
• Schibli DJ, Hunter HN, Aseyev V et al. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 277(10), 8279–8289 (2002).
   PubMed Web of Science ®Google Scholar
• Howell MD, Wollenberg A, Gallo RL et al. Cathelicidin deficiency predisposes to eczema herpeticum. J. Allergy. Clin. Immunol. 117(4), 836–841 (2006).
   PubMed Web of Science ®Google Scholar
• Howell MD. The role of human beta defensins and cathelicidins in atopic dermatitis. Curr. Opin. Allergy. Clin. Immunol. 7(5), 413–417 (2007).
   Google Scholar
• Aichberger KJ, Mittermann I, Reininger R et al. Hom s 4, an IgE-reactive autoantigen belonging to a new subfamily of calcium-binding proteins, can induce Th cell type 1-mediated autoreactivity. J. Immunol. 175(2), 1286–1294 (2005).
   PubMed Web of Science ®Google Scholar
• Mothes N, Niggemann B, Jenneck C et al. The cradle of IgE autoreactivity in atopic eczema lies in early infancy. J. Allergy. Clin. Immunol. 116(3), 706–709 (2005).
   Google Scholar
• Holick MF. Vitamin D: A millenium perspective. J. Cell. Biochem. 88(2), 296–307 (2003).
   PubMed Web of Science ®Google Scholar
• Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheum. Dis. Clin. North. Am. 38(1), 125–139 (2012).
   PubMed Web of Science ®Google Scholar
• Bikle DD, Chang S, Crumrine D et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J. Invest. Dermatol. 122(4), 984–992 (2004).
   PubMed Web of Science ®Google Scholar
• Realegeno S, Modlin RL. Shedding light on the vitamin D-tuberculosis-HIV connection. Proc. Natl. Acad. Sci .USA 108(47), 18861–18862 (2011).
   PubMed Web of Science ®Google Scholar
• Penna G, Amuchastegui S, Giarratana N et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178(1), 145–153 (2007).
   PubMed Web of Science ®Google Scholar
• Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164(5), 2405–2411 (2000).
   PubMed Web of Science ®Google Scholar
• Piemonti L, Monti P, Sironi M et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164(9), 4443–4451 (2000).
   PubMed Web of Science ®Google Scholar
• Manavalan JS, Rossi PC, Vlad G et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11(3–4), 245–258 (2003).
   PubMed Web of Science ®Google Scholar
• Penna G, Roncari A, Amuchastegui S et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106(10), 3490–3497 (2005).
   PubMed Web of Science ®Google Scholar
• Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98(12), 6800–6805 (2001).
   PubMed Web of Science ®Google Scholar
• Bock G, Prietl B, Mader JK et al. The effect of vitamin D supplementation on peripheral regulatory T cells and beta cell function in healthy humans: a randomized controlled trial. Diabetes Metab. Res. Rev. 27(8), 942–945 (2011).
   PubMedGoogle Scholar
• Milliken SV, Wassall H, Lewis BJ et al. Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function. J. Allergy. Clin. Immunol. 129(6), 1554–1561 (2012).
   PubMed Web of Science ®Google Scholar
• Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology 134(2), 123–139 (2011).
   PubMed Web of Science ®Google Scholar
• Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221(4616), 1181–1183 (1983).
   PubMed Web of Science ®Google Scholar
• Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179(3), 1634–1647 (2007).
   PubMed Web of Science ®Google Scholar
• Heine G, Anton K, Henz BM, Worm M. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur. J. Immunol. 32(12), 3395–3404 (2002).
   Google Scholar
• Yamanaka KI, Kakeda M, Kitagawa H et al. 1,24-dihydroxyvitamin D(3) (tacalcitol) prevents skin T-cell infiltration. Br. J. Dermatol. 162(6), 1206–1215 (2010).
   Google Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 167(9), 4974–4980 (2001).
   PubMed Web of Science ®Google Scholar
• Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J. Nutr. 125(6 Suppl.), 1704S–1708S (1995).
   PubMed Web of Science ®Google Scholar
• Jirapongsananuruk O, Melamed I, Leung DY. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses. J. Allergy. Clin. Immunol. 106(5), 981–985 (2000).
   PubMed Web of Science ®Google Scholar
• Staeva-Vieira TP, Freedman LP. 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol. 168(3), 1181–1189 (2002).
   PubMed Web of Science ®Google Scholar
• Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M, Willheim M. 1 alpha, 25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr. Res. 52(1), 12–18 (2002).
   PubMed Web of Science ®Google Scholar
• O'Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A, Koeffler HP. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J. Clin. Invest. 109(8), 1091–1099 (2002).
   PubMed Web of Science ®Google Scholar
• Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur. J. Immunol. 34(4), 1068–1076 (2004).
   PubMed Web of Science ®Google Scholar
• Kreindler JL, Steele C, Nguyen N et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J. Clin. Invest. 120(9), 3242–3254 (2010).
   PubMed Web of Science ®Google Scholar
• Olsen K, Falch BM, Danielsen K et al. Staphylococcus aureus nasal carriage is associated with serum 25-hydroxyvitamin D levels, gender and smoking status. The Tromso Staph and Skin Study. Eur. J. Clin. Microbiol. Infect. Dis. 31(4), 465–473 (2012).
   Google Scholar
• Kanda N, Hau CS, Tada Y, Sato S, Watanabe S. Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M. Allergy 67(6), 804–812 (2012).
   Google Scholar
• Hata TR, Kotol P, Jackson M et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J. Allergy. Clin. Immunol. 122(4), 829–831 (2008).
   Google Scholar
• Cardona ID, Cho SH, Leung DY. Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies. Am. J. Clin. Dermatol. 7(5), 273–279 (2006).
   PubMed Web of Science ®Google Scholar
• Bikle DD, Oda Y, Xie Z. Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J. Steroid. Biochem. Mol. Biol. 89–90(1–5), 355–360 (2004).
   Google Scholar
• Meindl S, Rot A, Hoetzenecker W, Kato S, Cross HS, Elbe-Burger A. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells. Br. J. Dermatol. 152(2), 231–241 (2005).
   PubMed Web of Science ®Google Scholar
• Hartmann B, Riedel R, Jorss K et al. Vitamin D receptor activation improves allergen-triggered eczema in mice. J. Invest. Dermatol. 132(2), 330–336 (2012).
   PubMed Web of Science ®Google Scholar
• Camargo CA, Clark S, Kaplan MS, Lieberman P, Wood RA. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J. Allergy. Clin. Immunol, 120(1), 131–136 (2007).
   PubMed Web of Science ®Google Scholar
• Oren E, Banerji A, Camargo CA. Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J. Allergy. Clin. Immunol. 121(2), 533–534 (2008).
   PubMed Web of Science ®Google Scholar
• Mullins RJ, Clark S, Camargo CA. Regional variation in infant hypoallergenic formula prescriptions in Australia. Pediatr. Allergy. Immunol. 21(2 Pt 2), e413–e420 (2010).
   PubMed Web of Science ®Google Scholar
• Sharief S, Jariwala S, Kumar J, Muntner P, Melamed ML. Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005–2006. J. Allergy. Clin. Immunol. 127(5), 1195–1202 (2011).
   PubMed Web of Science ®Google Scholar
• Vassallo MF, Banerji A, Rudders SA, Clark S, Mullins RJ, Camargo CA. Season of birth and food allergy in children. Ann. Allergy. Asthma Immunol. 104(4), 307–313 (2010).
   PubMedGoogle Scholar
• Mullins RJ, Camargo CA. Shining a light on vitamin D and its impact on the developing immune system. Clin. Exp. Allergy 41(6), 766–768 (2011).
   Google Scholar
• Imai S, Takeuchi S, Mashiko T. Seasonal changes in the course of atopic eczema. Hautarzt 38(10), 599–602 (1987).
   Google Scholar
• Tolppanen AM, Sayers A, Granell R, Fraser WD, Henderson J, Lawlor DA. Prospective association of 25-hydroxyvitamin d3 and d2 with childhood lung function, asthma, wheezing, and flexural dermatitis. Epidemiology 24(2), 310–319 (2013).
   PubMed Web of Science ®Google Scholar
• Hypponen E, Sovio U, Wjst M et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. N Y Acad. Sci. 1037, 84–95 (2004).
   PubMed Web of Science ®Google Scholar
• Rothers J, Wright AL, Stern DA, Halonen M, Camargo CA. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J. Allergy. Clin. Immunol. 128(5), 1093–1099 e1091–1095 (2011).
   PubMed Web of Science ®Google Scholar
• Wang TT, Tavera-Mendoza LE, Laperriere D et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 19(11), 2685–2695 (2005).
   PubMed Web of Science ®Google Scholar
• Poon AH, Laprise C, Lemire M et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am. J. Respir. Crit. Care Med. 170(9), 967–973 (2004).
   PubMed Web of Science ®Google Scholar
• Vollmert C, Illig T, Altmuller J et al. Single nucleotide polymorphism screening and association analysis–exclusion of integrin beta 7 and vitamin D receptor (chromosome 12q) as candidate genes for asthma. Clin. Exp. Allergy 34(12), 1841–1850 (2004).
   PubMed Web of Science ®Google Scholar
• Heine G, Hoefer N, Franke A et al. Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br. J. Dermatol. 168(4), 855–858 (2013).
   PubMed Web of Science ®Google Scholar
• Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 54(1), 1–15 (2006).
   PubMed Web of Science ®Google Scholar
• Ellison JA, Patel L, Ray DW, David TJ, Clayton PE. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 105(4 Pt 1), 794–799 (2000).
   PubMed Web of Science ®Google Scholar
• Ring J, Mohrenschlager M, Henkel V. The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy. Drug Saf. 31(3), 185–198 (2008).
   PubMed Web of Science ®Google Scholar
• Behnam SM, Behnam SE, Koo JY. Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use. J. Drugs Dermatol. 4(2), 189–194 (2005).
   PubMedGoogle Scholar
• Tintle S, Shemer A, Suarez-Farinas M et al. Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. J. Allergy Clin. Immunol. 128(3), 583–593 e581–584 (2011).
   PubMedGoogle Scholar
• Bath-Hextall FJ, Jenkinson C, Humphreys R, Williams HC. Dietary supplements for established atopic eczema. Cochrane. Database Syst. Rev. 2, CD005205 (2012).
   PubMed Web of Science ®Google Scholar
• Sidbury R, Sullivan AF, Thadhani RI, Camargo CA. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br. J. Dermatol. 159(1), 245–247 (2008).
   PubMed Web of Science ®Google Scholar
• Javanbakht MH, Keshavarz SA, Djalali M et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J. Dermatolog. Treat 22(3), 144–150 (2011).
   PubMed Web of Science ®Google Scholar
• Amestejani M, Salehi BS, Vasigh M et al. Vitamin D supplementation in the treatment of atopic dermatitis: a clinical trial study. J. Drugs Dermatol. 11(3), 327–330 (2012).
   PubMed Web of Science ®Google Scholar
• Hata TR, Audish D, Kotol P et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. doi:10.1111/jdv.12176 (2013) (Epub ahead of print).
   Google Scholar
• Samochocki Z, Bogaczewicz J, Jeziorkowska R et al. Vitamin D effects in atopic dermatitis. J. Am. Acad. Dermatol. 69(2), 238–244 (2013).
   PubMed Web of Science ®Google Scholar
• Dondi A, Ricci L, Neri I, Ricci G, Patrizi A. The switch from non-IgE-associated to IgE-associated atopic dermatitis occurs early in life. Allergy 68(2), 259–260 (2013).
   PubMed Web of Science ®Google Scholar